載入...
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial
BACKGROUND: SSG&PM over 17 days is recommended as first line treatment for visceral leishmaniasis in eastern Africa, but is painful and requires hospitalization. Combination regimens including AmBisome and miltefosine are safe and effective in India, but there are no published data from trials o...
Na minha lista:
| 發表在: | PLoS Negl Trop Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5023160/ https://ncbi.nlm.nih.gov/pubmed/27627654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0004880 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|